Composition
Granisetron Injection
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Graniberg contains Granisetron, a highly selective 5-HT3 receptor antagonist for the prevention of severe chemotherapy-induced nausea and vomiting.
Indication
Prevention and treatment of nausea and vomiting associated with emetogenic chemotherapy and radiotherapy.
Packaging
Single vial pack
Storage
Store below 25°C, protected from light. Use reconstituted solution as directed.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.